Corvus Pharmaceuticals CRVS
NASDAQ CRVS
$11.76 -0.11 (-0.93%)
At close: Sep 29, 2026 · 4:00 PM EDT

Corvus Pharmaceuticals (CRVS) Assets (2015 - 2026)

Updated

Corvus Pharmaceuticals (CRVS) posted Assets of $239.27 million for Q2 2026, up 167.5% from $89.46 million a year earlier but down 5.5% from the prior quarter.

Analysis

Corvus Pharmaceuticals (CRVS) Assets (2015 - 2026) Analysis & Trends

At the end of FY2025, Corvus Pharmaceuticals' Assets came in at $71.12 million, up 3.2% from FY2024.

  • Annual Assets shows a five-year compound annual growth rate of -3.6% (FY2020 to FY2025).
  • In prior years, Corvus Pharmaceuticals' Assets was $68.91 million in FY2024 (+51.3%), $45.55 million in FY2023 (-33.2%), $68.24 million in FY2022 (-37.7%) and $109.46 million in FY2021 (+28.0%).
  • Quarterly Assets has run from a low of $40.08 million in Q1 2024 to a high of $253.2 million in Q1 2026 over five years.
  • On a year-over-year basis, Assets has increased in each of the last nine quarters, with growth averaging 85.6% over the last eight quarters.
  • The strongest year-over-year quarter for Assets in the past five years was Q1 2026, with growth of 326.0%; the weakest was Q1 2023, with a decline of 42.5%.
  • According to Business Quant data, Assets for the three prior quarters was $253.2 million (Q1 2026), $71.12 million (Q4 2025) and $80.47 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 201.06 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 135.12 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 115.83 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 49.36 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 27.42 Bn
10 Corvus Pharmaceuticals 998.52 Mn 486.96 Mn - 239.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 239.27 Mn
Mar 31, 2026 253.20 Mn
Dec 31, 2025 71.12 Mn
Sep 30, 2025 80.47 Mn
Jun 30, 2025 89.46 Mn
Mar 31, 2025 59.44 Mn
Dec 31, 2024 68.91 Mn
Sep 30, 2024 58.82 Mn
Jun 30, 2024 64.56 Mn
Mar 31, 2024 40.08 Mn
Dec 31, 2023 45.55 Mn
Sep 30, 2023 51.94 Mn
Jun 30, 2023 58.04 Mn
Mar 31, 2023 58.20 Mn
Dec 31, 2022 68.24 Mn
Sep 30, 2022 80.35 Mn
Jun 30, 2022 92.54 Mn
Mar 31, 2022 101.29 Mn
Dec 31, 2021 109.46 Mn
Sep 30, 2021 119.32 Mn
API Access

Corvus Pharmaceuticals Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=CRVS&period=max&api_key=YOUR_API_KEY